VJHemOnc is committed to improving our service to you

ASCO 2019 | Iberdomide with dexamethasone for R/R multiple myeloma

VJHemOnc is committed to improving our service to you

Sagar Lonial

Sagar Lonial, MD, FACP, from the Winship Cancer Institute, Druid Hills, GA, discusses the rationale and results of the first study (NCT02773030) investigating iberdomide in combination with dexamethasone for R/R multiple myeloma. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter